Malignant Neoplasm of Unknown Primary — Research

Malignant Neoplasm of Unknown Primary — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	1,145	`("Malignant Neoplasm of Unknown Primary"[tiab] OR "Cancer of Unknown Primary"[tiab] OR "Cancer of Unknown Primary Site"[tiab] OR "cancer of unknown primary origin"[tiab] OR "Metastatic Malignant Neoplasm of Unknown Primary Origin"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	520	`("Malignant Neoplasm of Unknown Primary"[tiab] OR "Cancer of Unknown Primary"[tiab] OR "Cancer of Unknown Primary Site"[tiab] OR "cancer of unknown primary origin"[tiab] OR "Metastatic Malignant Neoplasm of Unknown Primary Origin"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	95	`("Malignant Neoplasm of Unknown Primary"[tiab] OR "Cancer of Unknown Primary"[tiab] OR "Cancer of Unknown Primary Site"[tiab] OR "cancer of unknown primary origin"[tiab] OR "Metastatic Malignant Neoplasm of Unknown Primary Origin"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (486)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 351–375 of 486 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.
· J Clin Invest · 2006 · PMID 16906227 · validated civic_curation pubmed
Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis.
· J Natl Cancer Inst · 2002 · PMID 11792751 · validated civic_curation pubmed
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
· Cancer Res · 2008 · PMID 18829560 · validated civic_curation pubmed
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.